255 related articles for article (PubMed ID: 31932552)
1. Moderate Levels of N-Terminal Pro-B-Type Natriuretic Peptide is Associated with Increased Risks of Total and Ischemic Strokes among Japanese: The Circulatory Risk in Communities Study.
Ebihara K; Yamagishi K; Umesawa M; Muraki I; Cui R; Imano H; Kubota Y; Hayama-Terada M; Shimizu Y; Ohira T; Sankai T; Okada T; Kitamura A; Kiyama M; Iso H;
J Atheroscler Thromb; 2020 Aug; 27(8):751-760. PubMed ID: 31932552
[TBL] [Abstract][Full Text] [Related]
2. NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and the Risk of Stroke.
Di Castelnuovo A; Veronesi G; Costanzo S; Zeller T; Schnabel RB; de Curtis A; Salomaa V; Borchini R; Ferrario M; Giampaoli S; Kee F; Söderberg S; Niiranen T; Kuulasmaa K; de Gaetano G; Donati MB; Blankenberg S; Iacoviello L;
Stroke; 2019 Mar; 50(3):610-617. PubMed ID: 30786848
[TBL] [Abstract][Full Text] [Related]
3. Troponin T, N-terminal pro-B-type natriuretic peptide, and incidence of stroke: the atherosclerosis risk in communities study.
Folsom AR; Nambi V; Bell EJ; Oluleye OW; Gottesman RF; Lutsey PL; Huxley RR; Ballantyne CM
Stroke; 2013 Apr; 44(4):961-7. PubMed ID: 23471272
[TBL] [Abstract][Full Text] [Related]
4. N-terminal pro-B-type natriuretic peptide and stroke risk: the reasons for geographic and racial differences in stroke cohort.
Cushman M; Judd SE; Howard VJ; Kissela B; Gutiérrez OM; Jenny NS; Ahmed A; Thacker EL; Zakai NA
Stroke; 2014 Jun; 45(6):1646-50. PubMed ID: 24757103
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
[TBL] [Abstract][Full Text] [Related]
6. Urinary N-terminal pro-B-type natriuretic peptide as a biomarker for cardiovascular events in a general Japanese population: the Hisayama Study.
Yamasaki K; Hata J; Ide T; Nagata T; Sakata S; Yoshida D; Honda T; Hirakawa Y; Nakano T; Kitazono T; Tsutsui H; Ninomiya T
Environ Health Prev Med; 2021 Apr; 26(1):47. PubMed ID: 33845756
[TBL] [Abstract][Full Text] [Related]
7. Time course and prognostic value of plasma levels of N-terminal pro-brain natriuretic peptide in patients after ischemic stroke.
Yip HK; Sun CK; Chang LT; Chen MC; Liou CW
Circ J; 2006 Apr; 70(4):447-52. PubMed ID: 16565563
[TBL] [Abstract][Full Text] [Related]
8. Plasma natriuretic peptides and incidence of subtypes of ischemic stroke.
Berntsson J; Zia E; Borné Y; Melander O; Hedblad B; Engström G
Cerebrovasc Dis; 2014; 37(6):444-50. PubMed ID: 25060145
[TBL] [Abstract][Full Text] [Related]
9. Association between increased N-terminal pro-brain natriuretic peptide level and poor clinical outcomes after acute ischemic stroke.
Yang J; Zhong C; Wang A; Xu T; Bu X; Peng Y; Wang J; Peng H; Li Q; Ju Z; Geng D; Zhang Y; He J;
J Neurol Sci; 2017 Dec; 383():5-10. PubMed ID: 29246621
[TBL] [Abstract][Full Text] [Related]
10. Combined effect of serum N-terminal pro-brain natriuretic peptide and galectin-3 on prognosis 1 year after ischemic stroke.
Liu Y; Guo D; Wang A; Yang J; Zhu Z; Xu T; Zhong C; Peng H; Chen J; Zhou Y; Zhang Y; He J
Clin Chim Acta; 2020 Dec; 511():33-39. PubMed ID: 32986993
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Serum N-Terminal Pro-Brain Natriuretic Peptide Level over Heart Failure for Stroke Events and Deaths in Patients with Atrial Fibrillation.
Kuronuma K; Okumura Y; Morikawa T; Yokoyama K; Matsumoto N; Tachibana E; Oiwa K; Matsumoto M; Kojima T; Haruta H; Nomoto K; Sonoda K; Arima K; Kogawa R; Takahashi F; Kotani T; Ohkubo K; Fukushima S; Itou S; Kondo K; Chiku M; Ohno Y; Onikura M; Hirayama A;
Int Heart J; 2020 May; 61(3):492-502. PubMed ID: 32418966
[TBL] [Abstract][Full Text] [Related]
12. Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy.
Longstreth WT; Kronmal RA; Thompson JL; Christenson RH; Levine SR; Gross R; Brey RL; Buchsbaum R; Elkind MS; Tirschwell DL; Seliger SL; Mohr JP; deFilippi CR
Stroke; 2013 Mar; 44(3):714-9. PubMed ID: 23339958
[TBL] [Abstract][Full Text] [Related]
13. N-terminal pro-brain natriuretic peptide predicts hospitalization for ischemic stroke in Japanese hemodialysis patients.
Yamaoka M; Yoshida M; Nakashima A; Doi S; Naito T; Masaki T
Clin Exp Nephrol; 2022 Nov; 26(11):1111-1118. PubMed ID: 35838853
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic value of N-terminal pro-brain natriuretic peptide in differentiating cardioembolic ischemic stroke.
Hajsadeghi S; Kashani Amin L; Bakhshandeh H; Rohani M; Azizian AR; Jafarian Kerman SR
J Stroke Cerebrovasc Dis; 2013 May; 22(4):554-60. PubMed ID: 23422348
[TBL] [Abstract][Full Text] [Related]
15. B-type natriuretic peptide over N-terminal pro-brain natriuretic peptide to predict incident atrial fibrillation after cryptogenic stroke.
Palà E; Pagola J; Juega J; Francisco-Pascual J; Bustamante A; Penalba A; Comas I; Rodriguez M; De Lera Alfonso M; Arenillas JF; de Torres R; Pérez-Sánchez S; Cabezas JA; Moniche F; González-Alujas T; Molina CA; Montaner J
Eur J Neurol; 2021 Feb; 28(2):540-547. PubMed ID: 33043545
[TBL] [Abstract][Full Text] [Related]
16. N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in a Japanese community: the Hisayama study.
Doi Y; Ninomiya T; Hata J; Hirakawa Y; Mukai N; Ikeda F; Fukuhara M; Iwase M; Kiyohara Y
Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2997-3003. PubMed ID: 21921261
[TBL] [Abstract][Full Text] [Related]
17. NT-proBNP and Risk of Dementia in a General Japanese Elderly Population: The Hisayama Study.
Nagata T; Ohara T; Hata J; Sakata S; Furuta Y; Yoshida D; Honda T; Hirakawa Y; Ide T; Kanba S; Kitazono T; Tsutsui H; Ninomiya T
J Am Heart Assoc; 2019 Sep; 8(17):e011652. PubMed ID: 31446828
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of N-terminal pro B-type natriuretic peptide for nonvalvular atrial fibrillation in acute ischemic stroke patients: A retrospective multicenter case-control study.
Zhao J; Zhang Y; Yuan F; Song C; Jiang Y; Gao Q; Leng X; Jiang W
J Neurol Sci; 2020 Jul; 414():116822. PubMed ID: 32278166
[TBL] [Abstract][Full Text] [Related]
19. N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).
Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Christersson C; Ezekowitz J; Gersh BJ; Hanna M; Hohnloser S; Horowitz J; Huber K; Hylek EM; Lopes RD; McMurray JJ; Granger CB
J Am Coll Cardiol; 2013 Jun; 61(22):2274-84. PubMed ID: 23563134
[TBL] [Abstract][Full Text] [Related]
20. N-terminal fragment of probrain natriuretic peptide is associated with diabetes microvascular complications in type 2 diabetes.
Hamano K; Nakadaira I; Suzuki J; Gonai M
Vasc Health Risk Manag; 2014; 10():585-9. PubMed ID: 25328404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
